Search research articles
Contact Us
Filters
Showing results (141-150 of 170) with videos related to
Page
of 17
Sort By:
Leukemia
|
June 19, 2013
Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia
O Kosmider, R Itzykson, V Chesnais, et al.
Clinical and Experimental Immunology
|
October 25, 2007
Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes
S Audia, A Nicolas, D Cathelin, et al.
Leukemia
|
July 11, 2008
Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum
E Gyan, E Frisan, O Beyne-Rauzy, et al.
Leukemia
|
April 9, 2010
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms
O Kosmider, V Gelsi-Boyer, L Slama, et al.
Blood Cancer Journal
|
January 3, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
M M Patnaik, E A Wassie, E Padron, et al.
Leukemia
|
February 24, 2001
Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes
E Solary, L Mannone, D Moreau, et al.
Blood Cancer Journal
|
February 14, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
M M Patnaik, E A Wassie, E Padron, et al.
Leukemia
|
April 24, 1999
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes
E Wattel, E Solary, X Leleu, et al.
Leukemia
|
May 22, 2013
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma
A Bouchekioua, L Scourzic, O de Wever, et al.
Blood
|
October 9, 1999
Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations
F Rieux-Laucat, S Blachère, S Danielan, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 170) with videos related to
Sort By:
Page
of 17
Leukemia
|
June 19, 2013
Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia
O Kosmider, R Itzykson, V Chesnais, et al.
Clinical and Experimental Immunology
|
October 25, 2007
Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes
S Audia, A Nicolas, D Cathelin, et al.
Leukemia
|
July 11, 2008
Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum
E Gyan, E Frisan, O Beyne-Rauzy, et al.
Leukemia
|
April 9, 2010
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms
O Kosmider, V Gelsi-Boyer, L Slama, et al.
Blood Cancer Journal
|
January 3, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
M M Patnaik, E A Wassie, E Padron, et al.
Leukemia
|
February 24, 2001
Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes
E Solary, L Mannone, D Moreau, et al.
Blood Cancer Journal
|
February 14, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
M M Patnaik, E A Wassie, E Padron, et al.
Leukemia
|
April 24, 1999
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes
E Wattel, E Solary, X Leleu, et al.
Leukemia
|
May 22, 2013
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma
A Bouchekioua, L Scourzic, O de Wever, et al.
Blood
|
October 9, 1999
Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations
F Rieux-Laucat, S Blachère, S Danielan, et al.
Page
of 17